Study to Image the Esophagus Using the OFDI Capsule
Pilot Study for Imaging of the Esophagus Using an OFDI Capsule
2 other identifiers
interventional
56
1 country
1
Brief Summary
The main purpose of this research is to test the feasibility and tolerability of the tethered capsule Optical Frequency Domain Imaging (OFDI)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2012
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2012
CompletedFirst Submitted
Initial submission to the registry
June 12, 2014
CompletedFirst Posted
Study publicly available on registry
July 30, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedResults Posted
Study results publicly available
April 23, 2019
CompletedApril 30, 2019
April 1, 2019
3.5 years
June 12, 2014
March 28, 2019
April 22, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Feasibility of OFDI Imaging in Subjects Swallowing the OFDI Capsule
Number of subjects from whom the quality OFDI imaging was obtained
Images will be acquired during the OFDI imaging session which should take an average of 5 minutes
Study Arms (1)
OFDI Capsule Imaging
EXPERIMENTALSubject will swallow the OFDI capsule and imaging will be acquired using the OFDI Imaging system.
Interventions
Eligibility Criteria
You may qualify if:
- A previous diagnosis of Barrett's Esophagus
- OR a previous diagnosis of EoE
- OR a previous diagnosis of Gastroesophageal reflux disease (GERD)
- Subject must be 18 years or older in case of Barrett's and GERD, and over the age of 16 years for EoE
- Subject must be able to give informed consent
You may not qualify if:
- Subjects with known esophageal strictures, intestinal strictures or dysphagia
- OR subjects with a history of prior GI surgery or GI Intestinal Crohn's disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Massachusetts General Hospitallead
- National Institutes of Health (NIH)collaborator
- National Cancer Institute (NCI)collaborator
Study Sites (1)
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Gary Tearney
- Organization
- Mass General Hospital
Study Officials
- PRINCIPAL INVESTIGATOR
Guillermo Tearney, MD., PhD
Massachusetts General Hospital
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 12, 2014
First Posted
July 30, 2014
Study Start
February 1, 2012
Primary Completion
July 31, 2015
Study Completion
July 1, 2016
Last Updated
April 30, 2019
Results First Posted
April 23, 2019
Record last verified: 2019-04
Data Sharing
- IPD Sharing
- Will not share